1. The use of different dialysis membranes in therapy of patients with multiple myeloma
- Author
-
Aleksandra Musiała, Maciej Szymczak, and Dorota Zielińska
- Subjects
medicine.medical_specialty ,Dialysis membranes ,Chemistry ,Urology ,Hemodiafiltration ,General Medicine ,Immunoglobulin light chain ,medicine.disease ,Membrane ,Renal Dialysis ,Kidney injury ,medicine ,Humans ,Effective treatment ,Immunoglobulin Light Chains ,Kidney Diseases ,In patient ,Multiple Myeloma ,Dialysis (biochemistry) ,Multiple myeloma - Abstract
Free light chains accumulation is the reason of kidney injury in patients with multiple myeloma. The removal of free light chains can improve patients prognosis and survival, and in some cases allows for dialysotherapy discontinuation. Unfortunately, conventional dialysis is not effective enough in terms of free light chains removal. New high cut-off (HCO) techniques remove free light chains more effectively than conventional dialysis. In some cases, this technique may turn out better than hemodiafiltration. However, there are some differences between specific techniques in the removal of kappa and lambda light chains. Lambda light chains are better removed by polymethyl methacrylate membranes with a change of filter during dialysis. Kappa light chains are thoroughly removed by polymethyl methacrylate membranes and HCO (35,000 Da) polysulfone membranes. Unfortunately, it is very difficult to differentiate between the effect of HCO dialysis therapy and concomitant chemotherapy because some of the data is not fully conclusive. Using the proper technique for an individual patient may give optimally effective treatment results.
- Published
- 2020